Epidermolysis bullosa acquisita: A retrospective clinical analysis of 30 cases

Acta Dermato-Venereologica

Volumn 91, Issue 3, 2011, Pages 307-312

  Kim, Jong Hoon ^a   Kim, Yeon Hee ^b   Kim, Soo Chan ^a  

^a Yonsei University College of Medicine   (South Korea)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Clinical study remission; Epidermolysis bullosa acqui sita; Retrospective study

Indexed keywords

AZATHIOPRINE; COLCHICINE; COMPLEMENT COMPONENT C3; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRUNSTING PERRY PEMPHIGOID LIKE TYPE; BULLOUS PEMPHIGOID; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DISEASE CLASSIFICATION; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG PULSE THERAPY; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS; MALE; MOUTH DISEASE; MUCOUS MEMBRANE PEMPHIGOID; ONSET AGE; PEMPHIGOID; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; WESTERN BLOTTING;

ADULT; AGED; COLCHICINE; DAPSONE; DRUG THERAPY, COMBINATION; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; MALE; METHYLPREDNISOLONE; MIDDLE AGED; REMISSION INDUCTION; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955709878     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1065     Document Type: Article

References (26)

1. Woodley DT, Briggaman RA, O'Keefe EJ, Inman AO, Queen LL, Gammon WR. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 1984; 310: 1007-1013.
2. Woodley DT, Burgeson RE, Lunstrum G, Bruckner-Tuderman L, Reese MJ, Briggaman RA. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest 1988; 81: 683-687.
3. Woodley DT, Chang C, Saadat P, Ram R, Liu Z, Chen M. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol 2005; 124: 958-964.
4. Roenigk HH Jr., Ryan JG, Bergfeld WF. Epidermolysis bullosa acquisita.Report of three cases and review of all published cases. Arch Dermatol 1971; 103: 1-10.
5. Gammon WR, Briggaman RA, Woodley DT, Heald PW, Wheeler CE Jr. Epidermolysis bullosa acquisita - a pemphigoid-like disease. J Am Acad Dermatol 1984; 11: 820-832.
6. Dahl MG. Epidermolysis bullosa acquisita - a sign of cica-tricial pemphigoid? Br J Dermatol 1979; 101: 475-484.
7. Kurzhals G, Stolz W, Meurer M, Kunze J, Braun-Falco O, Krieg T. Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid. Arch Dermatol 1991; 127: 391-395.
8. Hashimoto T, Ishiko A, Shimizu H, Tanaka T, Dodd HJ, Bhogal BS, et al. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies. Br J Der-matol 1996; 134: 336-339.
9. Remington J, Chen M, Burnett J, Woodley DT. Autoimmu-nity to type VII collagen: epidermolysis bullosa acquisita. Curr Dir Autoimmun 2008; 10: 195-205.
10. Hughes AP, Callen JP. Epidermolysis bullosa acquisita responsive to dapsone therapy. J Cutan Med Surg 2001; 5: 397-399.
11. Cunningham BB, Kirchmann TT, Woodley D. Colchicine for epidermolysis bullosa acquisita. J Am Acad Dermatol 1996; 34: 781-784.
12. Miller JL, Stricklin GP, Fine JD, King LE, Arzubiaga MC, Ellis DL. Remission of severe epidermolysis bullosa ac-quisita induced by extracorporeal photochemotherapy. Br J Dermatol 1995; 133: 467-471.
13. Meier F, Sonnichsen K, Schaumburg-Lever G, Dopfer R, Rassner G. Epidermolysis bullosa acquisita: effcacy of high-dose intravenous immunoglobulins. J Am Acad Dermatol 1993; 29: 334-337.
14. Delgado L, Aoki V, Santi C, Gabbi T, Sotto M, Maruta C. Clinical and immunopathological evaluation of epidermoly-sis bullosa acquisita. Clin Exp Dermatol 2010; 36: 12-18
15. Gammon WR, Heise ER, Burke WA, Fine JD, Woodley DT, Briggaman RA. Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol 1988; 91: 228-232.
16. Bernard P, Vaillant L, Labeille B, Bedane C, Arbeille B, Denoeux JP, et al. Incidence and distribution of subepi-dermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Der-matol 1995; 131: 48-52.
17. Zillikens D, Wever S, Roth A, Weidenthaler-Barth B, Hashimoto T, Brocker EB. Incidence of autoimmune subepider-mal blistering dermatoses in a region of central Germany. Arch Dermatol 1995; 131: 957-958.
18. Murrell DF, Dick S, Ahmed AR, Amagai M, Barnadas MA, Borradori L, et al. Consensus statement on defnitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol 2008; 58: 1043-1046.
19. Engineer L, Ahmed AR. Emerging treatment for epider-molysis bullosa acquisita. J Am Acad Dermatol 2001; 44: 818-828.
20. Hallel-Halevy D, Nadelman C, Chen M, Woodley DT. Epidermolysis bullosa acquisita: update and review. Clin Dermatol 2001; 19: 712-718.
21. Chen M, O'Toole EA, Sanghavi J, Mahmud N, Kelleher D, Weir D, et al. The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with crohn's disease have autoantibodies to type VII collagen. J Invest Dermatol 2002; 118: 1059-1064.
22. Ray TL, Levine JB, Weiss W, Ward PA. Epidermolysis bul-losa acquisita and infammatory bowel disease. J Am Acad Dermatol 1982; 6: 242-252.
23. Raab B, Fretzin DF, Bronson DM, Scott MJ, Roenigk HH Jr., Medenica M.Epidermolysis bullosa acquisita and in-fammatory bowel disease. JAMA 1983; 250: 1746-1748.
24. Kim ES, Kim WH. Infammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver 2010; 4: 1-14.
25. Ishii N, Hamada T, Dainichi T, Karashima T, Nakama T, Yasumoto S, et al. Epidermolysis bullosa acquisita: what's new? J Dermatol 2010; 37: 220-230.
26. Hughes BR, Horne J. Epidermolysis bullosa acquisita and total ulcerative colitis. J R Soc Med 1988; 81: 473-475.